Journal of the National Cancer Institute Advance Access originally published online on October 9, 2007
JNCI Journal of the National Cancer Institute 2007 99(20):1499-1501; doi:10.1093/jnci/djm186
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Published by Oxford University Press 2007.
EDITORIALS |
The Evidence for Prostate Cancer Risk Loci at 8q24 Grows Stronger
Affiliation of authors: Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD
Correspondence to: Sharon A. Savage, MD, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, EPS-7018, Rockville, MD 20892 (e-mail: savagesh@mail.nih.gov).
| The first 10% of the full text of this article appears below. |
Genetic association studies that implicate chromosome 8q24 polymorphisms as risk factors for cancer are appearing at an astounding rate. Chromosomal band 8q24 became a genomic region of interest when two separate studies (1,2) reported that markers within a 1-Mb region (127.9–128.0 Mb) at this locus are statistically significantly associated with an increased risk of prostate cancer. With astonishing speed, multiple studies replicated and/or found similar results in the same region (3–9) (Table 1). The designs of these studies included genotyping of single-nucleotide polymorphisms (SNPs) in the predefined 8q24 region (5–9) and genome-wide association studies (3,4). Some of the studies replicated published findings for the same specific SNPs, while others found associations in
Related Articles in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2007 99: 1525-1533.
J Natl Cancer Inst 2007 99: 1497.
This article has been cited by other articles:
![]() |
D. J Schaid Overview of Statistical Genetic Concepts for Pharmacogenomic Studies Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 465 - 469. [Abstract] [Full Text] [PDF] |
||||
